New Approaches To Neuroblastoma Therapy Consortium
Clinical trials sponsored by New Approaches To Neuroblastoma Therapy Consortium, explained in plain language.
-
New hope for tough childhood cancers: first trial of Triple-Drug attack
Disease control OngoingThis study is testing a new combination of three drugs for children and young adults whose neuroblastoma has returned or hasn't responded to standard treatments. The main goal is to find the highest dose of a drug called sorafenib that can be safely added to two other chemotherap…
Phase: PHASE1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists supercharge Kids' own immune cells to fight cancer
Disease control OngoingThis early-stage study is testing a new combination treatment for children and young adults whose neuroblastoma has come back or hasn't responded to standard therapies. Doctors take a patient's own natural killer (NK) immune cells, grow large numbers of them in a lab, and then in…
Phase: PHASE1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists hunt genetic clues in childhood cancer relapse
Knowledge-focused OngoingThis study aims to understand why neuroblastoma, a serious childhood cancer, comes back after treatment. Researchers will analyze tumor samples from children and young adults whose cancer has returned or hasn't responded to therapy. They're looking for specific genetic markers th…
Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC